Concurrent Investment Advisors »

Rhythm Pharmaceuticals shares owned by Concurrent Investment Advisors

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Concurrent Investment Advisors from 13F filings

Historical chart of Concurrent Investment Advisors investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Concurrent Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Concurrent Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $344k 7.5k 45.97

More positions owned by Concurrent Investment Advisors

Alphabet Cap Stk Cl A Call Option (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
First Tr Exchange-traded Dorsey Wrt 5 Etf (FV)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Value Etf (VTV)

View all positions for Concurrent Investment Advisors

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
BlackRock
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Vanguard Group
Perceptive Advisors
NEA Management Company
Federated Investors
Frazier Life Sciences Management
Rock Springs Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Commodore Capital
Checkpoint Capital

View all funds holding Rhythm Pharmaceuticals